NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

Michael Vogelbaum; Kristin Swanson; Peixin Zhang; Daniel Cahill; Andrea Hawkins-Daarud; Mark R Gilbert; Gustavo De Leon; Cassandra Rickertsen; Lauren Kunkel; Wenyin Shi; Marta Penas-Prado; Emad Youssef; Hui-Kuo Shu; Merideth Wendland; John Suh; John Keech; Steven Howard; Vesna Kaluza; Minhee Won; Minesh P Mehta

doi:10.1093/neuonc/nox168.649

NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

Michael Vogelbaum, Kristin Swanson, Peixin Zhang, Daniel Cahill, Andrea Hawkins-Daarud, Mark R Gilbert, Gustavo De Leon, Cassandra Rickertsen, Lauren Kunkel, Wenyin Shi, Marta Penas-Prado, Emad Youssef, Hui-Kuo Shu, Merideth Wendland, John Suh, John Keech, Steven Howard, Vesna Kaluza, Minhee Won, Minesh P Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	19
DOIs	https://doi.org/10.1093/neuonc/nox168.649
State	Published - Nov 6 2017

Disciplines

Medical Biophysics
Surgery
Other Medical Specialties

Access to Document

10.1093/neuonc/nox168.649License: Unspecified

Cite this

Vogelbaum, M., Swanson, K., Zhang, P., Cahill, D., Hawkins-Daarud, A., Gilbert, M. R., De Leon, G., Rickertsen, C., Kunkel, L., Shi, W., Penas-Prado, M., Youssef, E., Shu, H.-K., Wendland, M., Suh, J., Keech, J., Howard, S., Kaluza, V., Won, M., & Mehta, M. P. (2017). NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825. Neuro-oncology, 19. https://doi.org/10.1093/neuonc/nox168.649

Vogelbaum, M, Swanson, K, Zhang, P, Cahill, D, Hawkins-Daarud, A, Gilbert, MR, De Leon, G, Rickertsen, C, Kunkel, L, Shi, W, Penas-Prado, M, Youssef, E, Shu, H-K, Wendland, M, Suh, J, Keech, J, Howard, S, Kaluza, V, Won, M & Mehta, MP 2017, 'NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825', Neuro-oncology, vol. 19. https://doi.org/10.1093/neuonc/nox168.649

@article{55fb12490a7749b7880312ac081cc19f,

title = "NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825",

author = "Michael Vogelbaum and Kristin Swanson and Peixin Zhang and Daniel Cahill and Andrea Hawkins-Daarud and Gilbert, \{Mark R\} and \{De Leon\}, Gustavo and Cassandra Rickertsen and Lauren Kunkel and Wenyin Shi and Marta Penas-Prado and Emad Youssef and Hui-Kuo Shu and Merideth Wendland and John Suh and John Keech and Steven Howard and Vesna Kaluza and Minhee Won and Mehta, \{Minesh P\}",

note = "INTRODUCTIONRTOG 0825 randomized 621 newly-diagnosed glioblastoma patients to treatment with or without bevacizumab, in addition to standard-of-care radiotherapy plus concurrent/adjuvant temozolomide. No significant difference was seen between the treatment arms in overall survival (OS), and the difference in progression free survival (PFS) did not meet the pre-defined statistical margin.",

year = "2017",

month = nov,

day = "6",

doi = "10.1093/neuonc/nox168.649",

language = "American English",

volume = "19",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

AU - Vogelbaum, Michael

AU - Swanson, Kristin

AU - Zhang, Peixin

AU - Cahill, Daniel

AU - Hawkins-Daarud, Andrea

AU - Gilbert, Mark R

AU - De Leon, Gustavo

AU - Rickertsen, Cassandra

AU - Kunkel, Lauren

AU - Shi, Wenyin

AU - Penas-Prado, Marta

AU - Youssef, Emad

AU - Shu, Hui-Kuo

AU - Wendland, Merideth

AU - Suh, John

AU - Keech, John

AU - Howard, Steven

AU - Kaluza, Vesna

AU - Won, Minhee

AU - Mehta, Minesh P

N1 - INTRODUCTIONRTOG 0825 randomized 621 newly-diagnosed glioblastoma patients to treatment with or without bevacizumab, in addition to standard-of-care radiotherapy plus concurrent/adjuvant temozolomide. No significant difference was seen between the treatment arms in overall survival (OS), and the difference in progression free survival (PFS) did not meet the pre-defined statistical margin.

PY - 2017/11/6

Y1 - 2017/11/6

UR - http://academic.oup.com/neuro-oncology/article/19/suppl_6/vi159/4590923

U2 - 10.1093/neuonc/nox168.649

DO - 10.1093/neuonc/nox168.649

M3 - Article

VL - 19

JO - Neuro-oncology

JF - Neuro-oncology

ER -

NIMG-77. IMPACT OF POST-SURGICAL ENHANCING TUMOR VOLUME AND T2/FLAIR VOLUME ON THE SURVIVAL IMPACT OF BEVACIZUMAB IN NRG ONCOLOGY/RTOG 0825

Disciplines

Access to Document

Other files and links

Cite this